Vandana Singh

Contributing Author

Recent Articles by Vandana Singh

Feb-27	What's Going On With Novavax Stock On Friday? NVAX -9.38% SNY Benzinga
Feb-27	Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review ENSC +57.77% Benzinga
Feb-27	Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter DNA -30.48% Benzinga
Feb-27	ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% ANIP Benzinga
Feb-27	Generic Drugs Focused Amneal Pharmaceuticals Revenue Crosses $800 Million AMRX Benzinga
Feb-27	Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy NGNE +19.36% Benzinga
Feb-27	Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit Surprise CAI Benzinga
Feb-27	Why Is Duolingo Stock Sinking Friday? DUOL -14.01% Benzinga
Feb-26	Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths BSX Benzinga
Feb-26	Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients BMY Benzinga
Feb-26	COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb NVAX +17.42% NVAX -9.38% Benzinga
Feb-26	Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2 NVO LLY Benzinga
Feb-26	What's Driving Teladoc Health's Rally? TDOC +15.05% Benzinga
Feb-26	AtaiBeckley Touts Social Anxiety Breakthrough With Phase 2 Trial Data ATAI -14.06% Benzinga
Feb-26	Argenx Touts Positive Phase 3 Eye Disease Study Results ARGX -5.56% Benzinga
Feb-26	ImmunityBio Investors Rally Behind Cancer Trial Milestone IBRX Benzinga
Feb-26	IonQ Stock Gains, Europe's Quantum Leap Sparks Rally IONQ +21.70% Benzinga
Feb-26	PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why PRCT -15.12% Benzinga
Feb-26	Sarepta CEO To Jump Ship After 'Tumultuous' Year SRPT -8.01% DYN Benzinga
Feb-25	Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment PFE Benzinga
Feb-25	ImmunityBio Supersedes Expectations With Fivefold Revenue Increase IBRX -17.40% Benzinga
Feb-25	Ionis Guides Below 2026 Sales Views Despite Strong Growth From Lead Drug IONS -5.29% Benzinga
Feb-25	Acadia Healthcare Shares Surge 23% Following Q4 Revenue Beat, Capacity Growth ACHC +21.37% ACHC +6.96% Benzinga
Feb-25	Vanda Pharmaceuticals Breaks Through With FDA Approval, Decision Date For Skin Drug VNDA Benzinga
Feb-25	Gilead Snaps Up Arcellx For $115 Per Share - A $7.8 Billion Bet On Cancer Therapy GILD ACLX Benzinga
Feb-25	Ozempic Price War - Novo Nordisk Slashes Prices By 50% LLY NVO Benzinga
Feb-25	Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans IQV CRL Benzinga
Feb-25	Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested ENVB +9.09% ABBV Benzinga
Feb-25	GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play GSK RAPT Benzinga
Feb-24	Iovance Biotherapeutics Explodes Over 20% - Early Trial Data Sparks Investor Frenzy IOVA +30.80% Benzinga
Feb-24	Henry Schein Stock Hits 52-Week High - Here's Why HSIC Benzinga
Feb-24	Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System MBOT +23.90% Benzinga
Feb-24	Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition REGN SNY Benzinga
Feb-24	What's Going On With Vanda Pharma Stock Tuesday? VNDA Benzinga
Feb-24	What's Going On With Fulcrum Therapeutics Stock Tuesday? FULC -21.21% Benzinga
Feb-24	Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences HIMS Benzinga
Feb-24	What's Going On With Kyntra Bio Stock Tuesday? KYNB -9.57% PFE Benzinga
Feb-24	EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia NXL +15.06% Benzinga
Feb-24	Protara's Experimental Bladder Cancer Drug Shows Encouraging Results TARA -26.38% Benzinga
Feb-24	Why Is MacroGenics Stock Sinking Tuesday? MGNX Benzinga
Feb-24	Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why VIR +27.73% Benzinga
Feb-24	Novo Nordisk's China Obesity Drug Cuts Nearly One-Fifth Of Body Weight NVO LLY Benzinga
Feb-23	Viking Therapeutics Stock Gains Amid Obesity Drug Buzz NVO -16.43% VKTX +11.05% Benzinga
Feb-23	Bristol-Myers Touts Promising Data From Blood Disorder Study BMY Benzinga
Feb-23	ImmunityBio Explodes To Near 52-Week High As Bladder Cancer Drug Anktiva Drives Massive 700% Revenue Growth IBRX +17.50% IBRX +12.99% Benzinga
Feb-23	Novo Nordisk's Loss Is Eli Lilly's Gain NVO -16.43% LLY Benzinga
Feb-23	Gossamer Bio Plans FDA Talks After Narrow Miss In Key Pivotal Study, Stock Sinks GOSS -80.13% Benzinga
Feb-23	GRAIL Stock Tumbles - National Health Service Galleri Trial To Blame GRAL -14.30% Benzinga
Feb-23	Merck's Strategic Shift Signals New Growth Horizons MRK Benzinga
Feb-23	MoonLake Immunotherapeutics Data Shows Phase 2 Success For Chronic Back Pain MLTX Benzinga
Feb-23	Vanda Pharmaceuticals FDA Approval Dawns A New Era For Bipolar And Schizophrenia Treatment VNDA +41.49% Benzinga
Feb-23	FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application TEVA Benzinga
Feb-23	Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug ACLX +77.43% GILD Benzinga
Feb-23	Novo Nordisk Stock Hits 52-Week Low After Weight-Loss Drug Falls Short Against Eli Lilly's NVO -16.43% LLY Benzinga
Feb-20	Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook TNDM +32.67% Benzinga
Feb-20	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot PFE MRNA BNTX Benzinga
Feb-20	Takeda Shares Down After Entyvio Shows Strong Results In Ulcerative Colitis Trial In Children, Shows Potential To Address Treatment Gaps TAK Benzinga
Feb-20	ImmunityBio Taps 85-Person Sales Team to Launch Its Bladder Cancer Drug In European Countries IBRX Benzinga
Feb-20	FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer AZN XLV IYH ABBV Benzinga
Feb-20	Eli Lilly Breaks New Ground In Crohn's Disease Treatment LLY Benzinga
Feb-20	J&J Eyes Mega Sale Of DePuy Synthes In Orthopedics Breakup Push JNJ Benzinga
Feb-20	Ardelyx Lead Drug Growth Fails To Lift Sentiment, Stock Drops ARDX -14.99% Benzinga
Feb-20	Why Is Candel Therapeutics Stock Falling Friday? CADL -14.20% Benzinga
Feb-20	Why Grail Stock Is Sinking Friday GRAL -50.55% Benzinga
Feb-19	Rhythm Pharmaceuticals Is Well-Positioned, Analyst Says Could Capture Big Share Of Rare Obesity Market SLNO RYTM Benzinga
Feb-19	Tempus AI Stock Jumps As Mizuho Starts Coverage, Earnings Scheduled For Next Week TEM +6.77% ARKK ARKG Benzinga
Feb-19	Catheter Precision Divests Non-Core Assets As It Shifts Focus VTAK -6.47% Benzinga
Feb-19	Hims & Hers Health $1 Billion Eucalyptus Acquisition Fuels Global Expansion Dreams NVO HIMS Benzinga
Feb-19	What's Going On With Tiny AI-Tech Company Gaxos.ai On Thursday? GXAI +16.26% Benzinga
Feb-19	Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals ENVB +8.04% Benzinga
Feb-19	Merck Discloses Positive Data For Respiratory Syncytial Virus Antibody Treatment, Seeks FDA Nod For Broader Child Use GSK MRK Benzinga
Feb-19	Interactive Strength Acquires Subscription-Rich Ergatta In Growth Push TRNR Benzinga
Feb-19	Carlsmed Unveils Custom Cervical Plating Tech CARL +5.57% Benzinga
Feb-18	Aprea Therapeutics Advanced Cancer Trial Shows Promising Results, Stock Soars APRE +21.33% Benzinga
Feb-18	Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars PODD Benzinga
Feb-18	Danaher's Masimo Acquisition: Solid Financials, Conservative Growth Projections DHR MASI Benzinga
Feb-18	FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars MRNA +6.65% MRNA +6.08% XBI FBT Benzinga
Feb-18	Merck Inks AI Drug Discovery Deal With Mayo Clinic To Revolutionize Drug Discovery FDL PPH XLV MRK Benzinga
Feb-18	Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo LLY Benzinga
Feb-18	Sensei Biotherapeutics Stock Soars 230% After Faeth Deal SNSE +187.51% Benzinga
Feb-18	FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer ICLR +8.89% TAK JNJ SNY MRK Benzinga
Feb-18	Itchy Skin Conditions? Novartis' Pivotal Trial Success Shows Potential For Targeted Relief AG NVS Benzinga
Feb-18	Polestar Unleashes Its Biggest EV Blitz Yet PSNY HAIL Benzinga
Feb-18	Organigram Bets Big On Europe With Sanity Group Takeover OGI +8.66% BTI Benzinga
Feb-18	Tactile Systems Stock Smashes 52-Week High After Strong Quarter TCMD +17.83% Benzinga
Feb-18	FDA Expands Approval For Staar Surgical's Popular Implantable Lens STAA +8.40% ALC XHE Benzinga
Feb-17	Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment NMRA +10.62% AXSM JNJ Benzinga
Feb-17	Medtronic Reaffirms 2026 Outlook As Heart and Diabetes Units Drive Growth MDT Benzinga
Feb-17	Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner JNJ Benzinga
Feb-17	Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026 RLYB -10.17% Benzinga
Feb-17	Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans PLYX +64.32% Benzinga
Feb-17	Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial XUDV PFE FDL PJP Benzinga
Feb-17	Why Is ImmunityBio Stock Gaining Tuesday? BBP IBRX Benzinga
Feb-17	Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes OCUL -21.28% REGN SNY Benzinga
Feb-17	COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy CMPS +31.33% PSIL +6.12% Benzinga
Feb-17	OS Therapies Discloses 2026 Timeline For Lead Drug Regulatory Filings OSTX Benzinga
Feb-17	Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients TEVA SNY EIS IZRL ISRA Benzinga
Feb-17	Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients PINK DUNK LLY CGDV Benzinga
Feb-17	Europe Clears GSK's New Twice-Yearly Asthma Treatment GSK Benzinga
Feb-17	FDA Delays Disc Medicine's Rare Disease Drug IRON +17.19% Benzinga

Vandana Singh

Recent Articles by Vandana Singh

Upgrade your FINVIZ experience